Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Ng, Kevin Tak Pan ^a   Xu, Aimin ^a   Cheng, Qiao ^a   Guo, Dong Y ^a   Lim, Zophia Xue Hui ^a   Sun, Chris Kin Wai ^a   Fung, Jeffrey Hon Sing ^a   Poon, Ronnie Tung Ping ^a   Fan, Sheung T ^a   Lo, Chung M ^a   Man, Kwan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiogenesis; Angiopoietin like 4; Hepatocellular carcinoma; Metastasis; Therapeutic

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN LIKE PROTEIN 4; ANTINEOPLASTIC AGENT; CASPASE 7; CASPASE 9; CD30 LIGAND; CD30T ANTIGEN; CD34 ANTIBODY; CD40 ANTIGEN; CRG2 PROTEIN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL16 CHEMOKINE; EOTAXIN; F ACTIN; L SELECTIN; MACROPHAGE ELASTASE; PROTEIN; PROTEIN BCL 2; STNFR1 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TCA 3 PROTEIN; TECK PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANGIOPOIETIN; ANGPTL4 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY DENSITY; CELL MOTILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; CPG ISLAND; CYTOKINE RELEASE; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LIVER HISTOLOGY; LIVER RESECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROMOTER REGION; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR THROMBUS; UPREGULATION; WESTERN BLOTTING; ADENOVIRIDAE; ADMINISTRATION AND DOSAGE; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; LIVER NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; ANGIOPOIETINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CPG ISLANDS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION;

EID: 84906836551     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-196     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Zhu AX. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?. Oncologist 2006, 11:790-800. 10.1634/theoncologist.11-7-790, 16880238.
3. Worns MA, Weinmann A, Schuchmann M, Galle PR. Systemic therapies in hepatocellular carcinoma. Dig Dis 2009, 27:175-188. 10.1159/000218351, 19546557.
4. Yau T, Chan P, Epstein R, Poon RT. Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol 2008, 14:6437-6441. 10.3748/wjg.14.6437, 2773326, 19030192.
5. Yau T, Chan P, Epstein R, Poon RT. Management of advanced hepatocellular carcinoma in the era of targeted therapy. Liver Int 2009, 29:10-17. 10.1111/j.1478-3231.2008.01916.x, 19120940.
6. Tan MJ, Teo Z, Sng MK, Zhu P, Tan NS. Emerging roles of Angiopoietin-like 4 in human cancer. Mol Cancer Res 2012, 10:677-688. 10.1158/1541-7786.MCR-11-0519, 22661548.
7. Zhu P, Goh YY, Chin HF, Kersten S, Tan NS. Angiopoietin-like 4: a decade of research. Biosci Rep 2012, 32:211-219. 10.1042/BSR20110102, 22458843.
8. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, Hesselink MK, Schrauwen P, Muller M. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol 2009, 29:969-974. 10.1161/ATVBAHA.108.182147, 19342599.
9. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006, 281:934-944. 10.1074/jbc.M506519200, 16272564.
10. Lu B, Moser A, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 2010, 391:1737-1741. 10.1016/j.bbrc.2009.12.145, 20043872.
11. Nakayama T, Hirakawa H, Shibata K, Nazneen A, Abe K, Nagayasu T, Taguchi T. Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis. Oncol Rep 2011, 25:929-935.
12. Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B, Winnard PT, Raman V, Zhen L, Mitzner WA, Sukumar S, Semenza GL. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 2012, 31:1757-1770. 10.1038/onc.2011.365, 3223555, 21860410.
13. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, Kersten S, Li HY, Ding JL, Tan NS. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011, 19:401-415. 10.1016/j.ccr.2011.01.018, 21397862.
14. Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Molinolo A, Sodhi A, Montaner S. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proc Natl Acad Sci U S A 2010, 107:14363-14368. 10.1073/pnas.1001065107, 2922606, 20660728.
15. Kim SH, Park YY, Kim SW, Lee JS, Wang D, DuBois RN. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res 2011, 71:7010-7020. 10.1158/0008-5472.CAN-11-1262, 3217078, 21937683.
16. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, Mekid H, Mir LM, Opolon P, Corvol P, Monnot C, Germain S. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A 2006, 103:18721-18726. 10.1073/pnas.0609025103, 1693729, 17130448.
17. Li H, Ge C, Zhao F, Yan M, Hu C, Jia D, Tian H, Zhu M, Chen T, Jiang G, Xie H, Cui Y, Gu J, Tu H, He X, Yao M, Liu Y, Li J. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology 2011, 54:910-919. 10.1002/hep.24479, 21674552.
18. Zhang H, Wei S, Ning S, Jie Y, Ru Y, Gu Y. Evaluation of TGFbeta, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC. Exp Ther Med 2013, 5:119-127. 3523953, 23251252.
19. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW, Lam KS. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 2005, 102:6086-6091. 10.1073/pnas.0408452102, 1087912, 15837923.
20. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 2009, 28:65-76. 10.1007/s10555-008-9170-7, 19160018.
21. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
22. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, Li H, Zhou H, Trent JM. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Gene Chromosome Canc 2000, 29:110-116.
23. Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T, Katsura N, Nishitai R, Takeyama O, Fukumoto M, Yamaoka Y. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 2000, 31:1073-1079. 10.1053/he.2000.6409, 10796882.
24. Qin LX, Tang ZY, Ye SL, Liu YK, Ma ZC, Zhou XD, Wu ZQ, Lin ZY, Sun FX, Tian J, Guan XY, Pack SD, Zhuang ZP. Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared. J Cancer Res Clin Oncol 2001, 127:482-488. 10.1007/s004320100236, 11501747.
25. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res 2002, 62:6645-6650.
26. Hattori N, Okochi-Takada E, Kikuyama M, Wakabayashi M, Yamashita S, Ushijima T. Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. Cancer Sci 2011, 102:1337-1343. 10.1111/j.1349-7006.2011.01955.x, 21489049.
27. Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol 2011, 8:292-301. 10.1038/nrclinonc.2011.30, 3266719, 21386818.
28. Wysocki PJ. Targeted therapy of hepatocellular cancer. Expert Opin Investig Drugs 2010, 19:265-274. 10.1517/13543780903514110, 20074016.
29. Coulouarn C, Corlu A, Glaise D, Guenon I, Thorgeirsson SS, Clement B. Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res 2012, 72:2533-2542. 10.1158/0008-5472.CAN-11-3317, 3498759, 22419664.
30. Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tessitore A, Zazzeroni F, Alesse E. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013, 2013:187204. 3591180, 23533994.
31. Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer 2011, 47:2299-2305. 10.1016/j.ejca.2011.05.032, 21683576.
32. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 2008, 29:2096-2105. 10.1093/carcin/bgn203, 18765415.
33. Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST. Suppression of liver tumor growth and metastasis by Adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho Kinase/IFN-inducible protein 10/Matrix metalloproteinase 9 signaling. Clin Cancer Res 2010, 16:967-977. 10.1158/1078-0432.CCR-09-1487, 20103676.
34. Ng KT, Man K, Sun CK, Lee TK, Poon RT, Lo CM, Fan ST. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer 2006, 95:1050-1055. 10.1038/sj.bjc.6603399, 2360701, 17008870.
35. Ng KT, Lo CM, Guo DY, Qi X, Li CX, Geng W, Liu XB, Ling CC, Ma YY, Yeung WH, Shao Y, Poon RT, Fan ST, Man K. Identification of transmembrane protein 98 as a novel chemoresistance-conferring gene in hepatocellular carcinoma. Mol Cancer Ther 2014, 13:1285-1297. 10.1158/1535-7163.MCT-13-0806, 24608572.
36. Ng KT, Guo DY, Cheng Q, Geng W, Ling CC, Li CX, Liu XB, Ma YY, Lo CM, Poon RT, Fan ST, Man K. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS ONE 2012, 7:e31655. 10.1371/journal.pone.0031655, 3289621, 22389672.
37. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 2002, 20:1775-1785. 10.1200/JCO.2002.07.089, 11919234.